1. Home
  2. NTRB vs MCHX Comparison

NTRB vs MCHX Comparison

Compare NTRB & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRB
    SELLHOLDBUYas of 2 days ago
  • MCHX
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • NTRB 2016
  • MCHX 2003
  • Country
  • NTRB United States
  • MCHX United States
  • Employees
  • NTRB N/A
  • MCHX N/A
  • Industry
  • NTRB Industrial Specialties
  • MCHX Business Services
  • Sector
  • NTRB Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • NTRB Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • NTRB 77.9M
  • MCHX 79.9M
  • IPO Year
  • NTRB N/A
  • MCHX 2004
  • Fundamental
  • Price
  • NTRB $4.08
  • MCHX $1.99
  • Analyst Decision
  • NTRB
  • MCHX
  • Analyst Count
  • NTRB 0
  • MCHX 0
  • Target Price
  • NTRB N/A
  • MCHX N/A
  • AVG Volume (30 Days)
  • NTRB 30.2K
  • MCHX 110.2K
  • Earning Date
  • NTRB 12-04-2024
  • MCHX 10-31-2024
  • Dividend Yield
  • NTRB N/A
  • MCHX N/A
  • EPS Growth
  • NTRB N/A
  • MCHX N/A
  • EPS
  • NTRB N/A
  • MCHX N/A
  • Revenue
  • NTRB $2,021,771.00
  • MCHX $48,594,000.00
  • Revenue This Year
  • NTRB N/A
  • MCHX N/A
  • Revenue Next Year
  • NTRB N/A
  • MCHX $4.63
  • P/E Ratio
  • NTRB N/A
  • MCHX N/A
  • Revenue Growth
  • NTRB N/A
  • MCHX N/A
  • 52 Week Low
  • NTRB $2.22
  • MCHX $1.11
  • 52 Week High
  • NTRB $9.60
  • MCHX $2.40
  • Technical
  • Relative Strength Index (RSI)
  • NTRB 40.82
  • MCHX 53.19
  • Support Level
  • NTRB $3.87
  • MCHX $1.98
  • Resistance Level
  • NTRB $4.80
  • MCHX $2.15
  • Average True Range (ATR)
  • NTRB 0.51
  • MCHX 0.17
  • MACD
  • NTRB 0.04
  • MCHX -0.01
  • Stochastic Oscillator
  • NTRB 21.21
  • MCHX 36.92

Stock Price Comparison Chart: NTRB vs MCHX

NTRB
MCHX
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober012345678910NTRB VS MCHX

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks:

By browsing this website, you accept our Privacy Policy & Terms of Use